Pierluigi Paggiaro
- Microparticles-associated tissue factor activity is increased in bronchoalveolar lavage of patients with pulmonary fibrosis and correlates with functional impairmentBy Federica Novelli, Tommaso Neri, Concettina Noce, Laura Tavanti, Stella Cini, Federica Martino, Alessandro Celi and Pierluigi PaggiaroFederica NovelliCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, PI, ItalyTommaso NeriCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, PI, ItalyConcettina NoceCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, PI, ItalyLaura TavantiCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, PI, ItalyStella CiniCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, PI, ItalyFederica MartinoCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, PI, ItalyAlessandro CeliCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, PI, ItalyPierluigi PaggiaroCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, PI, Italy
- Flow limitation at rest may identify a phenotype of chronic obstructive pulmonary disease (COPD)By Laura Malagrinò, Francesco Costa, Barbara Vagaggini, Claudia De Simone, Cristina Spanu, Alessandro Celi and Pierluigi PaggiaroLaura MalagrinòCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyFrancesco CostaCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyBarbara VagagginiCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyClaudia De SimoneCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyCristina SpanuCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyAlessandro CeliCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyPierluigi PaggiaroCardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy
- Oxidative stress induces the generation of tissue factor bearing microparticles by airway epithelial cells in vitroBy Concettina Noce, Tommaso Neri, Federica Novelli, Cinzia Cordazzo, Silvia Petrini, Yuri Carmazzi, Laura Tavanti, Pierluigi Paggiaro and Alessandro CeliConcettina NoceCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, PI, ItalyTommaso NeriCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, PI, ItalyFederica NovelliCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, PI, ItalyCinzia CordazzoCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, PI, ItalySilvia PetriniCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, PI, ItalyYuri CarmazziCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, PI, ItalyLaura TavantiCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, PI, ItalyPierluigi PaggiaroCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, PI, ItalyAlessandro CeliCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, PI, Italy
- Maintenance of long term benefits from an outpatient pulmonary rehabilitation programme in COPDBy Francesco Costa, Laura Malagrinò, Sandra Antonelli, Claudia De Simone, Giovanna Decusatis, Dario Nieri, Sabrina Santerini, Barbara Vagaggini and Pierluigi PaggiaroFrancesco CostaCardiothoracic and Vascular, University, Pisa, ItalyLaura MalagrinòCardiothoracic and Vascular, University, Pisa, ItalySandra AntonelliCardiothoracic and Vascular, University, Pisa, ItalyClaudia De SimoneCardiothoracic and Vascular, University, Pisa, ItalyGiovanna DecusatisCardiothoracic and Vascular, University, Pisa, ItalyDario NieriCardiothoracic and Vascular, University, Pisa, ItalySabrina SanteriniCardiothoracic and Vascular, University, Pisa, ItalyBarbara VagagginiCardiothoracic and Vascular, University, Pisa, ItalyPierluigi PaggiaroCardiothoracic and Vascular, University, Pisa, Italy
- Sputum eosinophil levels in corticosteroid-treated asthmatic patientsBy Elena Bacci, Manuela Latorre, Silvana Cianchetti, Federico Dente, Antonella Di Franco, Lorenza Melosini, Federica Novelli, Erika Camici and Pierluigi PaggiaroElena BacciCardioThoracic and Vascular Department, University of Pisa, Pisa, ItalyManuela LatorreCardioThoracic and Vascular Department, University of Pisa, Pisa, ItalySilvana CianchettiCardioThoracic and Vascular Department, University of Pisa, Pisa, ItalyFederico DenteCardioThoracic and Vascular Department, University of Pisa, Pisa, ItalyAntonella Di FrancoCardioThoracic and Vascular Department, University of Pisa, Pisa, ItalyLorenza MelosiniCardioThoracic and Vascular Department, University of Pisa, Pisa, ItalyFederica NovelliCardioThoracic and Vascular Department, University of Pisa, Pisa, ItalyErika CamiciCardioThoracic and Vascular Department, University of Pisa, Pisa, ItalyPierluigi PaggiaroCardioThoracic and Vascular Department, University of Pisa, Pisa, Italy
- Physiology is a better predictor of mortality than HRTC findings in patients with fibrotic idiopathic interstitial pneumoniaBy Federica Novelli, Laura Tavanti, Federica Martino, Stella Cini, Lorenza Melosini, Chiara Romei, Fabio Falaschi, Stefano Solfanelli, Alessandro Celi and Pierluigi PaggiaroFederica Novelli1Cardiac, Thoracic and Vascular Department, University of Pisa, Pisa, ItalyLaura Tavanti1Cardiac, Thoracic and Vascular Department, University of Pisa, Pisa, ItalyFederica Martino1Cardiac, Thoracic and Vascular Department, University of Pisa, Pisa, ItalyStella Cini1Cardiac, Thoracic and Vascular Department, University of Pisa, Pisa, ItalyLorenza Melosini2Radiology Department, University of Pisa, Pisa, ItalyChiara Romei2Radiology Department, University of Pisa, Pisa, ItalyFabio Falaschi1Cardiac, Thoracic and Vascular Department, University of Pisa, Pisa, ItalyStefano Solfanelli1Cardiac, Thoracic and Vascular Department, University of Pisa, Pisa, ItalyAlessandro Celi1Cardiac, Thoracic and Vascular Department, University of Pisa, Pisa, ItalyPierluigi Paggiaro1Cardiac, Thoracic and Vascular Department, University of Pisa, Pisa, Italy
- Anti-inflammatory effect of beclomethasone dipropionate and formoterol on TNF-α-induced human endothelial cell activationBy Silvana Cianchetti, Cristina Cardini, Gabriele Nicolini, Alessandro Celi and Pierluigi PaggiaroSilvana CianchettiCardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy Medical Affairs, Chiesi Farmaceutici S.p.A., Parma, Italy Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyCristina CardiniCardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy Medical Affairs, Chiesi Farmaceutici S.p.A., Parma, Italy Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyGabriele NicoliniCardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy Medical Affairs, Chiesi Farmaceutici S.p.A., Parma, Italy Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyAlessandro CeliCardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy Medical Affairs, Chiesi Farmaceutici S.p.A., Parma, Italy Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyPierluigi PaggiaroCardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy Medical Affairs, Chiesi Farmaceutici S.p.A., Parma, Italy Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy
- Montelukast as add-on therapy may improve some indices of small airways involvement in uncontrolled asthmaticsBy Laura Malagrinò, Francesco Costa, Lorenza Melosini, Antonella Di Franco, Giosuè Catapano and Pierluigi PaggiaroLaura Malagrinò1Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyFrancesco Costa1Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyLorenza Melosini1Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyAntonella Di Franco1Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyGiosuè Catapano2Institute of Clinical Physiology, CNR, Pisa, ItalyPierluigi Paggiaro1Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy
- Dyspnoea and fat free mass are major determinants of reduced physical activity in COPD patientsBy Francesco Costa, Gianna De Cusatis, Laura Malagrinò, Sandra Antonelli, Claudia De Simone, Sabrina Santerini, Barbara Vagaggini and Pierluigi PaggiaroFrancesco CostaCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyGianna De CusatisCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyLaura MalagrinòCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalySandra AntonelliCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyClaudia De SimoneCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalySabrina SanteriniCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyBarbara VagagginiCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyPierluigi PaggiaroCardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy
- Asthma control and lung function after step down from high dose ICS/LABA combination therapyBy Pierluigi Paggiaro, Gabriele Nicolini, Nunzio Crimi, Leonardo Maria Fabbri, Dario Olivieri, Andrea Rossi and Alberto PapiPierluigi Paggiaro1Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyGabriele Nicolini2Medical Affairs, Chiesi Farmaceutici, Parma, ItalyNunzio Crimi3Department of Internal and Specialistic Medicine, Section of Respiratory Diseases, University of Catania, Catania, ItalyLeonardo Maria Fabbri4Section of Respiratory Diseases, University of Modena, Modena, ItalyDario Olivieri5Department of Clinical Sciences, University of Parma, Parma, ItalyAndrea Rossi6Department of Pneumology, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, ItalyAlberto Papi7Research Center on Asthma and COPD, University of Ferrara, Ferrara, Italy
- FEV1 decline and eosinophilia in occupational asthmaBy Donatella Talini, Federica Novelli, Elena Bacci, Maria Laura Bartoli, Silvana Cianchetti, Federico Lorenzo Dente, Antonella Di Franco, Lorenza Melosini and Pierluigi PaggiaroDonatella Talini1Prevention Department, Occupational Health Unit, Pisa, ItalyFederica Novelli2Cardiac, Thoracic and Vascular Department, University of Pisa, Pisa, ItalyElena Bacci2Cardiac, Thoracic and Vascular Department, University of Pisa, Pisa, ItalyMaria Laura Bartoli2Cardiac, Thoracic and Vascular Department, University of Pisa, Pisa, ItalySilvana Cianchetti2Cardiac, Thoracic and Vascular Department, University of Pisa, Pisa, ItalyFederico Lorenzo Dente2Cardiac, Thoracic and Vascular Department, University of Pisa, Pisa, ItalyAntonella Di Franco2Cardiac, Thoracic and Vascular Department, University of Pisa, Pisa, ItalyLorenza Melosini2Cardiac, Thoracic and Vascular Department, University of Pisa, Pisa, ItalyPierluigi Paggiaro2Cardiac, Thoracic and Vascular Department, University of Pisa, Pisa, Italy
- Late-breaking abstract: Bi-level positive airway pressure (Bipap) effects on regional distribution of lung ventilation in COPDBy Piera Fazzi, Renza Cristofani, Alfredo d'Abrosca, Maria Stella Derlin and Pierluigi PaggiaroPiera FazziCardiothoracic and Vascular Department, University of Pisa, Pisa, Italy Experimental Pathology, Medical Biotechnology, Infectious Disease and Epidemiology Department, University of Pisa, Pisa, Italy Regional Center of Nuclear Medicine, University of Pisa, Pisa, Italy Cardiothoracic and Vascular Department, University of Pisa, Pisa, Italy Cardiothoracic and Vascular Department, University of Pisa, Pisa, ItalyRenza CristofaniCardiothoracic and Vascular Department, University of Pisa, Pisa, Italy Experimental Pathology, Medical Biotechnology, Infectious Disease and Epidemiology Department, University of Pisa, Pisa, Italy Regional Center of Nuclear Medicine, University of Pisa, Pisa, Italy Cardiothoracic and Vascular Department, University of Pisa, Pisa, Italy Cardiothoracic and Vascular Department, University of Pisa, Pisa, ItalyAlfredo d'AbroscaCardiothoracic and Vascular Department, University of Pisa, Pisa, Italy Experimental Pathology, Medical Biotechnology, Infectious Disease and Epidemiology Department, University of Pisa, Pisa, Italy Regional Center of Nuclear Medicine, University of Pisa, Pisa, Italy Cardiothoracic and Vascular Department, University of Pisa, Pisa, Italy Cardiothoracic and Vascular Department, University of Pisa, Pisa, ItalyMaria Stella DerlinCardiothoracic and Vascular Department, University of Pisa, Pisa, Italy Experimental Pathology, Medical Biotechnology, Infectious Disease and Epidemiology Department, University of Pisa, Pisa, Italy Regional Center of Nuclear Medicine, University of Pisa, Pisa, Italy Cardiothoracic and Vascular Department, University of Pisa, Pisa, Italy Cardiothoracic and Vascular Department, University of Pisa, Pisa, ItalyPierluigi PaggiaroCardiothoracic and Vascular Department, University of Pisa, Pisa, Italy Experimental Pathology, Medical Biotechnology, Infectious Disease and Epidemiology Department, University of Pisa, Pisa, Italy Regional Center of Nuclear Medicine, University of Pisa, Pisa, Italy Cardiothoracic and Vascular Department, University of Pisa, Pisa, Italy Cardiothoracic and Vascular Department, University of Pisa, Pisa, Italy
- Tiotropium provides sustained bronchodilation in asthmatics with persistent airflow obstruction uncontrolled despite treatment in accordance with guidelinesBy Huib Kerstjens, Pierluigi Paggiaro, Mark Vandewalker, Ekkehard Beck, Michael Engel, Ralf Sigmund, Wolfgang Seibold, Petra Moroni-Zentgraf and Eric BatemanHuib Kerstjens1Department of Pulmonary Medicine and Tuberculosis, University Medical Center, Groningen, NetherlandsPierluigi Paggiaro2Dipartimento Cardio-Toracico, U.O. Pneumologia e Fisiopatologia Respiratoria, Ospedale di Cisanello, Pisa, ItalyMark Vandewalker3Clinical Trials, Clinical Research of the Ozarks, Columbia, MO, United StatesEkkehard Beck4Medical Department, IFG - Institut für Gesundheitsförderung GmbH, Rüdersdorf Brandenburg, GermanyMichael Engel5TA Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, GermanyRalf Sigmund6Biostatistics, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, GermanyWolfgang Seibold7Clinical Research, Germany, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, GermanyPetra Moroni-Zentgraf8TA Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, GermanyEric Bateman9Department of Medicine, University of Cape Town, South Africa
- Intensity of training and physiologic and clinical changes after pulmonary rehabilitation programme in patients chronic obstructive pulmonary diseaseBy Barbara Vagaggini, Francesco Costa, Laura Malagrinò, Laura Pazzaglia, Sandra Antonelli, Giovanna Decusatis, Claudia De Simone, Sabrina Santerini and Pierluigi PaggiaroBarbara Vagaggini1Cardiothoracic and Vascular Department, University, Pisa, ItalyFrancesco Costa1Cardiothoracic and Vascular Department, University, Pisa, ItalyLaura Malagrinò1Cardiothoracic and Vascular Department, University, Pisa, ItalyLaura Pazzaglia1Cardiothoracic and Vascular Department, University, Pisa, ItalySandra Antonelli1Cardiothoracic and Vascular Department, University, Pisa, ItalyGiovanna Decusatis1Cardiothoracic and Vascular Department, University, Pisa, ItalyClaudia De Simone1Cardiothoracic and Vascular Department, University, Pisa, ItalySabrina Santerini1Cardiothoracic and Vascular Department, University, Pisa, ItalyPierluigi Paggiaro1Cardiothoracic and Vascular Department, University, Pisa, Italy
- Laboratory exercise tests are not representative of the real physical activity in more severe COPD patientsBy Francesco Costa, Laura Malagrinò, Gianna Decusatis, Sandra Antonelli, Claudia De Simone, Sabrina Santerini, Barbara Vagaggini and Pierluigi PaggiaroFrancesco Costa1Cardiothoracic and Vascular Department, University of Pisa, ItalyLaura Malagrinò1Cardiothoracic and Vascular Department, University of Pisa, ItalyGianna Decusatis1Cardiothoracic and Vascular Department, University of Pisa, ItalySandra Antonelli1Cardiothoracic and Vascular Department, University of Pisa, ItalyClaudia De Simone1Cardiothoracic and Vascular Department, University of Pisa, ItalySabrina Santerini1Cardiothoracic and Vascular Department, University of Pisa, ItalyBarbara Vagaggini1Cardiothoracic and Vascular Department, University of Pisa, ItalyPierluigi Paggiaro1Cardiothoracic and Vascular Department, University of Pisa, Italy
- Effect of beclomethasone dipropionate, formoterol and their combination on TNF-α-induced ICAM-1 and IL-8 expression in human bronchial epithelial cellsBy Silvana Cianchetti, Cristina Cardini, Gabriele Nicolini, Alessandro Celi and Pierluigi PaggiaroSilvana Cianchetti1Cardiothoracic and Vascular Department, University of Pisa, ItalyCristina Cardini1Cardiothoracic and Vascular Department, University of Pisa, ItalyGabriele Nicolini2Medical Affairs Department, Chiesi Farmaceutici S.p.A., Parma, ItalyAlessandro Celi1Cardiothoracic and Vascular Department, University of Pisa, ItalyPierluigi Paggiaro1Cardiothoracic and Vascular Department, University of Pisa, Italy
- Characterisation of patients with difficult-to-treat and treatment-resistant severe asthmaBy Federica Novelli, Federico Lorenzo Dente, Maria Laura Bartoli, Silvana Cianchetti, Antonella Di Franco, Lorenza Melosini, Elena Bacci and Pierluigi PaggiaroFederica Novelli1Cardiothoracic and Vascular Department, University of Pisa, ItalyFederico Lorenzo Dente1Cardiothoracic and Vascular Department, University of Pisa, ItalyMaria Laura Bartoli1Cardiothoracic and Vascular Department, University of Pisa, ItalySilvana Cianchetti1Cardiothoracic and Vascular Department, University of Pisa, ItalyAntonella Di Franco1Cardiothoracic and Vascular Department, University of Pisa, ItalyLorenza Melosini1Cardiothoracic and Vascular Department, University of Pisa, ItalyElena Bacci1Cardiothoracic and Vascular Department, University of Pisa, ItalyPierluigi Paggiaro1Cardiothoracic and Vascular Department, University of Pisa, Italy
- Baseline airway inflammation may be a determinant of ozone response in asthmatic patientsBy Maria Laura Bartoli, Barbara Vagaggini, Laura Malagrinò, Elena Bacci, Silvana Cianchetti, Federico Dente, Francesco Costa and Pierluigi PaggiaroMaria Laura Bartoli1Cardiothoracic and Vascular Department, University of Pisa, ItalyBarbara Vagaggini1Cardiothoracic and Vascular Department, University of Pisa, ItalyLaura Malagrinò1Cardiothoracic and Vascular Department, University of Pisa, ItalyElena Bacci1Cardiothoracic and Vascular Department, University of Pisa, ItalySilvana Cianchetti1Cardiothoracic and Vascular Department, University of Pisa, ItalyFederico Dente1Cardiothoracic and Vascular Department, University of Pisa, ItalyFrancesco Costa1Cardiothoracic and Vascular Department, University of Pisa, ItalyPierluigi Paggiaro1Cardiothoracic and Vascular Department, University of Pisa, Italy
- Work-related asthma among a general asthma population: A cross sectional surveyBy Donatella Talini, Dusca Bartoli, Alessandro Ciberti, Paolo Del Guerra, Andrea Innocenti, Maria Lemmi, Anna Cerrano, Tonina Iaia, Francesco Di Pede, Laura Carrozzi and Pierluigi PaggiaroDonatella Talini1CeRIMP, Tuscany Regional Adm, Pisa, ItalyDusca Bartoli2Prevention Dpt, Occupational Health Unit, Empoli, ItalyAlessandro Ciberti2Prevention Dpt, Occupational Health Unit, Empoli, ItalyPaolo Del Guerra2Prevention Dpt, Occupational Health Unit, Empoli, ItalyAndrea Innocenti3Prevention Dpt, Occupational Health Unit, Pistoia, ItalyMaria Lemmi4Prevention Dpt, Occupational Health Unit, Pisa, ItalyAnna Cerrano5Prevention Dpt, Occupational Health Unit, Siena, ItalyTonina Iaia2Prevention Dpt, Occupational Health Unit, Empoli, ItalyFrancesco Di Pede6Institute of Clinical Physiology, CNR, Pisa, ItalyLaura Carrozzi7Cardiothoracic Dpt, University of Pisa, ItalyPierluigi Paggiaro7Cardiothoracic Dpt, University of Pisa, Italy
- Lung function efficacy of olodaterol QD delivered via Respimat® vs placebo and formoterol BID in patients with COPD: Two 48-week studiesBy Andrea Koch, Emilio Pizzichini, Alan Hamilton, Lorna Hart, Lawrence Korducki, Maria Cristina De Salvo and Pierluigi PaggiaroAndrea Koch1Medizinische Klinik III for Pneumology, Allergology and Sleep-Medicine, University Hospital Bochum-Bergmannsheil, Bochum, GermanyEmilio Pizzichini2NUPAIVA (Asthma Research Centre), Universidade Federal De Santa Catarina, Santa Catarina, BrazilAlan Hamilton3Boehringer Ingelheim, Burlington, ON, CanadaLorna Hart3Boehringer Ingelheim, Burlington, ON, CanadaLawrence Korducki4Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, United StatesMaria Cristina De Salvo5Centro Médico Dra. De Salvo, Fundación Respirar, Buenos Aires, ArgentinaPierluigi Paggiaro6Dipartimento Cardio-Toracico e Vascolare, Università Di Pisa, Pisa, Italy
- Cardiopulmonary exercise test (CPET) may show initial left cardiac dysfunction in patients with moderate-severe chronic obstructive pulmonary disease (COPD)By Francesco Costa, Barbara Vagaggini, Frank Dini, Laura Malagrinò, Sandra Antonelli, Claudia De Simone, Gianna De Cusatis, Sabrina Santerini and Pierluigi PaggiaroFrancesco Costa1Cardiothoracic, University, Pisa, ItalyBarbara Vagaggini1Cardiothoracic, University, Pisa, ItalyFrank Dini1Cardiothoracic, University, Pisa, ItalyLaura Malagrinò1Cardiothoracic, University, Pisa, ItalySandra Antonelli1Cardiothoracic, University, Pisa, ItalyClaudia De Simone1Cardiothoracic, University, Pisa, ItalyGianna De Cusatis1Cardiothoracic, University, Pisa, ItalySabrina Santerini1Cardiothoracic, University, Pisa, ItalyPierluigi Paggiaro1Cardiothoracic, University, Pisa, Italy
- Symptomatic benefit of olodaterol QD delivered via Respimat® vs placebo and formoterol BID in patients with COPD: Combined analysis from two 48-week studiesBy Andrea Koch, Pierluigi Paggiaro, Alan Hamilton, Lorna Hart, Lawrence Korducki, Maria Cristina De Salvo and Emilio PizzichiniAndrea Koch1Medizinische Klinik III for Pneumology, Allergology and Sleep-Medicine, University Hospital Bochum-Bergmannsheil, Bochum, GermanyPierluigi Paggiaro2Dipartimento Cardio-Toracico e Vascolare, Università Di Pisa, Pisa, ItalyAlan Hamilton3Boehringer Ingelheim, Burlington, ON, CanadaLorna Hart3Boehringer Ingelheim, Burlington, ON, CanadaLawrence Korducki4Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, United StatesMaria Cristina De Salvo5Centro Médico Dra. De Salvo, Fundación Respirar, Buenos Aires, ArgentinaEmilio Pizzichini6NUPAIVA (Asthma Research Centre), Universidade Federal De Santa Catarina, Santa Catarina, Brazil
- FORWARD: A study of extrafine beclomethasone/formoterol compared with formoterol alone in patients with severe COPD and a history of exacerbationsBy Alvar Agusti, Massimo Corradi, Geraldine Cohuet, Stefano Vezzoli, Dave Singh, Jorgen Vestbo, Pierluigi Paggiaro, Paul Jones, Stefano Petruzzelli and Jawidga WedzichaAlvar Agusti1Thorax Institute, Hospital Clinic, University of Barcelona, FISIB-CIBER Enfermedades Respiratorias (CIBERES), Mallorca, Barcelona, SpainMassimo Corradi2Department of Clinical and Experimental Medicine, University of Parma, Parma, ItalyGeraldine Cohuet3Chiesi Farmaceutici, Sponsor, Parma, ItalyStefano Vezzoli3Chiesi Farmaceutici, Sponsor, Parma, ItalyDave Singh4Medicines Evaluation Unit, University Hospital of South Manchester, Manchester, United KingdomJorgen Vestbo5Respiratory & Allergy Research Group, Manchester Academic Health Sciences Centre, South Manchester University Hospital, Manchester, United KingdomPierluigi Paggiaro6Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyPaul Jones7Clinical Science, St. George's, University of London, London, United KingdomStefano Petruzzelli3Chiesi Farmaceutici, Sponsor, Parma, ItalyJawidga Wedzicha8Centre for Respiratory Medicine, Royal Free Campus, University College London, London, United Kingdom
- Systemic inflammation and exercise tolerance in COPDBy Francesco Costa, Laura Malagrinò, Tommaso Nieri, Silvana Cianchetti, Sandra Antonelli, Giovanna De Cusatis, Claudia De Simone, Sabrina Santerini, Barbara Vagaggini and Pierluigi PaggiaroFrancesco Costa1Respiratory Pathophysiology and Pulmonary Rehabilitation Unit, University Hospital of Pisa, Pisa, ItalyLaura Malagrinò1Respiratory Pathophysiology and Pulmonary Rehabilitation Unit, University Hospital of Pisa, Pisa, ItalyTommaso Nieri1Respiratory Pathophysiology and Pulmonary Rehabilitation Unit, University Hospital of Pisa, Pisa, ItalySilvana Cianchetti1Respiratory Pathophysiology and Pulmonary Rehabilitation Unit, University Hospital of Pisa, Pisa, ItalySandra Antonelli1Respiratory Pathophysiology and Pulmonary Rehabilitation Unit, University Hospital of Pisa, Pisa, ItalyGiovanna De Cusatis1Respiratory Pathophysiology and Pulmonary Rehabilitation Unit, University Hospital of Pisa, Pisa, ItalyClaudia De Simone1Respiratory Pathophysiology and Pulmonary Rehabilitation Unit, University Hospital of Pisa, Pisa, ItalySabrina Santerini1Respiratory Pathophysiology and Pulmonary Rehabilitation Unit, University Hospital of Pisa, Pisa, ItalyBarbara Vagaggini1Respiratory Pathophysiology and Pulmonary Rehabilitation Unit, University Hospital of Pisa, Pisa, ItalyPierluigi Paggiaro1Respiratory Pathophysiology and Pulmonary Rehabilitation Unit, University Hospital of Pisa, Pisa, Italy
- Milan PM10 induces the release of microparticles by human mononuclear cellsBy Tommaso Neri, Eleonora Marta Longhin, Silvia Petrini, Maurizio Gualtieri, Stefania Lombardi, Yuri Carmazzi, Balia Cristina, Valentina Scalise, Marina Camatini, Roberto Pedrinelli, Pierluigi Paggiaro and Alessandro CeliTommaso Neri1Department of Surgical, Medical, Molecular Pathology and Critical area, University of Pisa, Pisa, ItalyEleonora Marta Longhin2Research Center "POLARIS", University Milano Bicocca, Milano, ItalySilvia Petrini1Department of Surgical, Medical, Molecular Pathology and Critical area, University of Pisa, Pisa, ItalyMaurizio Gualtieri2Research Center "POLARIS", University Milano Bicocca, Milano, ItalyStefania Lombardi3SSD Immunology, Allergy and Molecular Pathology, USL 1, Massa e Carrara, Massa e Carrara, ItalyYuri Carmazzi1Department of Surgical, Medical, Molecular Pathology and Critical area, University of Pisa, Pisa, ItalyBalia Cristina1Department of Surgical, Medical, Molecular Pathology and Critical area, University of Pisa, Pisa, ItalyValentina Scalise1Department of Surgical, Medical, Molecular Pathology and Critical area, University of Pisa, Pisa, ItalyMarina Camatini2Research Center "POLARIS", University Milano Bicocca, Milano, ItalyRoberto Pedrinelli1Department of Surgical, Medical, Molecular Pathology and Critical area, University of Pisa, Pisa, ItalyPierluigi Paggiaro1Department of Surgical, Medical, Molecular Pathology and Critical area, University of Pisa, Pisa, ItalyAlessandro Celi1Department of Surgical, Medical, Molecular Pathology and Critical area, University of Pisa, Pisa, Italy
- Effect of rehabilitation course in COPD patients with emphysema phenotypeBy Elena Venturelli, Guido Vagheggini, Katia Foglio, Pierluigi Paggiaro, Francesco de Blasio, Franco Pasqua, Gherardo Siscaro, Fabrizio Mezzasalma, Michele Vitacca, Ernesto Crisafulli, Nicolino Ambrosino and Enrico M. CliniElena Venturelli1DU Medical and Surgical Sciences, University of Modena, Modena, Italy2Rehabilitation Unit, Ospedale Villa Pineta, Pavullo n/F, Modena, ItalyGuido Vagheggini3Pulmonary Rehabilitation Unit, Auxilium Vitae, Volterra, Pisa, ItalyKatia Foglio4Pulmonary Rehabilitation Unit, Fondazione Maugeri IRCCS, Lumezzane, Brescia, ItalyPierluigi Paggiaro5Cardio-Thoracic and Vascular Dpt, University of Pisa, Pisa, ItalyFrancesco de Blasio6Pulmonary Rehabilitation Unit, Clinic Center, Napoli, ItalyFranco Pasqua7Pulmonary Rehabilitation Unit, San Raffaele Hospital, Velletri, Roma, ItalyGherardo Siscaro1DU Medical and Surgical Sciences, University of Modena, Modena, ItalyFabrizio Mezzasalma3Pulmonary Rehabilitation Unit, Auxilium Vitae, Volterra, Pisa, ItalyMichele Vitacca4Pulmonary Rehabilitation Unit, Fondazione Maugeri IRCCS, Lumezzane, Brescia, ItalyErnesto Crisafulli1DU Medical and Surgical Sciences, University of Modena, Modena, ItalyNicolino Ambrosino3Pulmonary Rehabilitation Unit, Auxilium Vitae, Volterra, Pisa, ItalyEnrico M. Clini1DU Medical and Surgical Sciences, University of Modena, Modena, Italy2Rehabilitation Unit, Ospedale Villa Pineta, Pavullo n/F, Modena, Italy
- Once-daily tiotropium respimat add-on to at least ICS in adult patients with symptomatic asthma: Pooled safety analysisBy Daniel Dusser, Roland Buhl, Mario Castro, Huib Kerstjens, Pierluigi Paggiaro, Michael Engel, Petra Moroni-Zentgraf, Anna Unseld and Eric BatemanDaniel Dusser1Pulmonary Department and Adult Cystic Fibrosis Center, Université Paris Descartes, Sorbonne Paris Cité, Cochin Hospital, Paris, FranceRoland Buhl2Pulmonary Department, Mainz University Hospital, Mainz, GermanyMario Castro3Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO,Huib Kerstjens4Department of Pulmonary Medicine and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, NetherlandsPierluigi Paggiaro5Cardio-Thoracic and Vascular Department, University Hospital of Pisa, Pisa, ItalyMichael Engel6TA Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co., Ingelheim am Rhein, GermanyPetra Moroni-Zentgraf6TA Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co., Ingelheim am Rhein, GermanyAnna Unseld7Global Biometrics and Clinical Applications, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, GermanyEric Bateman8Department of Medicine, University of Cape Town, Cape Town, South Africa
- High dose extrafine beclomethasone/formoterol via metered dose inhaler is effective and safe in asthmatics not controlled on medium-high dose of inhaled corticosteroidsBy Pierluigi Paggiaro, Massimo Corradi, Helene Raptis, Roberta Baronio, Christian Gessner, Zenon Siergiejko, Mario Scuri and Stefano PetruzzelliPierluigi Paggiaro1Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyMassimo Corradi2Department of Clinical and Experimental Medicine, University of Parma, Parma, ItalyHelene Raptis3Corporate Clinical Development, Chiesi Farmaceutici, Parma, ItalyRoberta Baronio3Corporate Clinical Development, Chiesi Farmaceutici, Parma, ItalyChristian Gessner4Department of Respiratory Medicine, University of Leipzig, POIS Leipzig GbR, Leipzig, GermanyZenon Siergiejko5Respiratory System Diagnostics and Bronchoscopy Department, Medical University of Bialystok, Bialystok, PolandMario Scuri3Corporate Clinical Development, Chiesi Farmaceutici, Parma, ItalyStefano Petruzzelli3Corporate Clinical Development, Chiesi Farmaceutici, Parma, Italy
- Physical activity improved significantly in patients with chronic obstructive pulmonary disease non responrders to an outpatient pulmonary rehabilitation program (PRP)By Laura Malagrinò, Barbara Vagaggini, Francesco Costa, Gianna Decusatis, Claudia De Simone, Sandra Antonelli, Sabrina Santerini, Giulia Lenzini and Pierluigi PaggiaroLaura Malagrinò1Cardiothoracic and Vascular, University, Pisa, ItalyBarbara Vagaggini1Cardiothoracic and Vascular, University, Pisa, ItalyFrancesco Costa1Cardiothoracic and Vascular, University, Pisa, ItalyGianna Decusatis1Cardiothoracic and Vascular, University, Pisa, ItalyClaudia De Simone1Cardiothoracic and Vascular, University, Pisa, ItalySandra Antonelli1Cardiothoracic and Vascular, University, Pisa, ItalySabrina Santerini1Cardiothoracic and Vascular, University, Pisa, ItalyGiulia Lenzini1Cardiothoracic and Vascular, University, Pisa, ItalyPierluigi Paggiaro1Cardiothoracic and Vascular, University, Pisa, Italy
- Once-daily tiotropium respimat add-on to ICS±LABA improves control across asthma severitiesBy J. Mark FitzGerald, Huib Kerstjens, Pierluigi Paggiaro, Ken Ohta, Masakazu Ichinose, Petra Moroni-Zentgraf, Michael Engel, Hendrik Schmidt and Eric BatemanJ. Mark FitzGerald1Institute for Heart and Lung Health, University of British Columbia, Vancouver, CanadaHuib Kerstjens2Department of Pulmonary Medicine and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, NetherlandsPierluigi Paggiaro3Cardio-Thoracic and Vascular Department, University Hospital of Pisa, Pisa, ItalyKen Ohta4National Hospital Organization, Tokyo National Hospital, Tokyo, JapanMasakazu Ichinose5Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, JapanPetra Moroni-Zentgraf6TA Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, GermanyMichael Engel6TA Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, GermanyHendrik Schmidt7Global Biometrics and Clinical Applications, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, GermanyEric Bateman8Department of Medicine, University of Cape Town, Cape Town, South Africa
- Late-breaking abstract: Cluster analysis of objectively measured physical activity in 1001 COPD patientsBy Rafael Mesquita, Gabriele Spina, Fabio Pitta, David Donaire-Gonzalez, Brenda M. Deering, Mehul S. Patel, Katy E. Mitchell, Jennifer Alison, Arnoldus J. R. van Gestel, Stefanie Zogg, Philippe Gagnon, Beatriz Abascal-Bolado, Barbara Vagaggini, Judith Garcia-Aymerich, Sue C. Jenkins, Elisabeth A. P. M. Romme, Samantha S.C. Kon, Paul S. Albert, Benjamin Waschki, Dinesh Shrikrishna, Sally J. Singh, Nicholas S. Hopkinson, David Miedinger, Roberto P. Benzo, François Maltais, Pierluigi Paggiaro, Zoe J. McKeough, Michael I. Polkey, Kylie Hill, William D-C. Man, Christian F. Clarenbach, Nidia A. Hernandes, Daniela Savi, Sally Wootton, Karina C. Furlanetto, Li W. Cindy Ng, Anouk W. Vaes, Christine Jenkins, Peter R. Eastwood, Diana Jarreta, Anne Kirsten, Dina Brooks, David R. Hillman, Thaís Sant'Anna, Kenneth Meijer, Selina Dürr, Malcolm Kohler, Vanessa S. Probst, Ruth Tal-Singer, Esther Garcia Gil, Jörg D. Leuppi, Peter M.A. Calverley, Frank W. J. M. Smeenk, Richard W. Costello, Marco Gramm, Roger Goldstein, Miriam Groenen, Helgo Magnussen, Emiel F.M. Wouters, Richard L. ZuWallack, Oliver Amft, Henrik Watz and Martijn A. SpruitRafael Mesquita1Department of Research & Education, Center of Expertise for Chronic Organ Failure+ (CIRO+), Horn, Netherlands2Department of Respiratory Medicine, Maastricht University Medical Center+ (MUMC+), Maastricht, NetherlandsGabriele Spina3Department of Signal Processing Systems, Technische Universiteit Eindhoven, Eindhoven, Netherlands4Smart Sensing and Analysis Group, Philips Research, Eindhoven, NetherlandsFabio Pitta5Laboratório de Pesquisa em Fisioterapia Pulmonar, Departamento de Fisioterapia, Universidade Estadual de Londrina (UEL), Londrina, Paraná, BrazilDavid Donaire-Gonzalez6Centre for Research in Environmental Epidemiology (CREAL), Barcelona, SpainBrenda M. Deering7Department of Respiratory Medicine, Beaumont Hospital, Dublin, IrelandMehul S. Patel8NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, United KingdomKaty E. Mitchell9NIHR EM CLAHRC - Centre for Exercsie and Rehabilitation Science, University Hospitals, Leicester, United KingdomJennifer Alison10Clinical and Rehabilitation Sciences, The University of Sydney, Sydney, NSW, Australia11Physiotherapy Department, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaArnoldus J. R. van Gestel12Pulmonary Division, University Hospital of Zurich, Zurich, SwitzerlandStefanie Zogg13Medical University Clinic, Cantonal Hospital Baselland, Liestal and Medical Faculty, University of Basel, Basel, SwitzerlandPhilippe Gagnon14Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, CanadaBeatriz Abascal-Bolado15Division of Pulmonary, Hospital U. Marqués de Valdecilla, IFIMAV, Santander, Spain16Mindful Breathing Laboratory, Mayo Clinic, Rochester, MN,Barbara Vagaggini17Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyJudith Garcia-Aymerich6Centre for Research in Environmental Epidemiology (CREAL), Barcelona, SpainSue C. Jenkins18School of Physiotherapy and Exercise Science, Curtin University, Perth, WA, AustraliaElisabeth A. P. M. Romme19Department of Respiratory Medicine, Catharina Hospital, Eindhoven, NetherlandsSamantha S.C. Kon8NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, United KingdomPaul S. Albert20School of Ageing and Chronic Disease, University Hospital Aintree, Liverpool, United KingdomBenjamin Waschki21Pulmonary Research Institute at LungClinic Grosshansdorf, Airway Research Center North, Member of the German Centre for Lung Research, Grosshansdorf, GermanyDinesh Shrikrishna8NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, United KingdomSally J. Singh9NIHR EM CLAHRC - Centre for Exercsie and Rehabilitation Science, University Hospitals, Leicester, United KingdomNicholas S. Hopkinson8NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, United KingdomDavid Miedinger13Medical University Clinic, Cantonal Hospital Baselland, Liestal and Medical Faculty, University of Basel, Basel, SwitzerlandRoberto P. Benzo16Mindful Breathing Laboratory, Mayo Clinic, Rochester, MN,François Maltais14Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, CanadaPierluigi Paggiaro17Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyZoe J. McKeough10Clinical and Rehabilitation Sciences, The University of Sydney, Sydney, NSW, AustraliaMichael I. Polkey8NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, United KingdomKylie Hill18School of Physiotherapy and Exercise Science, Curtin University, Perth, WA, AustraliaWilliam D-C. Man8NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, United KingdomChristian F. Clarenbach12Pulmonary Division, University Hospital of Zurich, Zurich, SwitzerlandNidia A. Hernandes5Laboratório de Pesquisa em Fisioterapia Pulmonar, Departamento de Fisioterapia, Universidade Estadual de Londrina (UEL), Londrina, Paraná, BrazilDaniela Savi22Department of Pediatrics and Pediatric Neurology, Cystic Fibrosis Center, Sapienza University of Rome, Rome, ItalySally Wootton10Clinical and Rehabilitation Sciences, The University of Sydney, Sydney, NSW, AustraliaKarina C. Furlanetto5Laboratório de Pesquisa em Fisioterapia Pulmonar, Departamento de Fisioterapia, Universidade Estadual de Londrina (UEL), Londrina, Paraná, BrazilLi W. Cindy Ng18School of Physiotherapy and Exercise Science, Curtin University, Perth, WA, AustraliaAnouk W. Vaes1Department of Research & Education, Center of Expertise for Chronic Organ Failure+ (CIRO+), Horn, NetherlandsChristine Jenkins23Woolcock Institute of Medical Research, The University of Sydney, Camperdown, NSW, AustraliaPeter R. Eastwood24Department of Pulmonary Physiology, Sir Charles Gairdner Hospital, Perth, WA, AustraliaDiana Jarreta25R&D Centre, Almirall, Barcelona, SpainAnne Kirsten21Pulmonary Research Institute at LungClinic Grosshansdorf, Airway Research Center North, Member of the German Centre for Lung Research, Grosshansdorf, GermanyDina Brooks26Respiratory Medicine, West Park Healthcare Centre, Toronto, CanadaDavid R. Hillman24Department of Pulmonary Physiology, Sir Charles Gairdner Hospital, Perth, WA, AustraliaThaís Sant'Anna5Laboratório de Pesquisa em Fisioterapia Pulmonar, Departamento de Fisioterapia, Universidade Estadual de Londrina (UEL), Londrina, Paraná, BrazilKenneth Meijer27Department of Human Movement Science, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, NetherlandsSelina Dürr13Medical University Clinic, Cantonal Hospital Baselland, Liestal and Medical Faculty, University of Basel, Basel, SwitzerlandMalcolm Kohler12Pulmonary Division, University Hospital of Zurich, Zurich, SwitzerlandVanessa S. Probst5Laboratório de Pesquisa em Fisioterapia Pulmonar, Departamento de Fisioterapia, Universidade Estadual de Londrina (UEL), Londrina, Paraná, Brazil28Centro de Pesquisa em Ciências da Saúde, Centro de Ciências Biológicas e da Saúde, Universidade Norte do Paraná (UNOPAR), Londrina, Paraná, BrazilRuth Tal-Singer29GlaxoSmithKline, King of Prussia, PA,Esther Garcia Gil25R&D Centre, Almirall, Barcelona, SpainJörg D. Leuppi13Medical University Clinic, Cantonal Hospital Baselland, Liestal and Medical Faculty, University of Basel, Basel, SwitzerlandPeter M.A. Calverley20School of Ageing and Chronic Disease, University Hospital Aintree, Liverpool, United KingdomFrank W. J. M. Smeenk19Department of Respiratory Medicine, Catharina Hospital, Eindhoven, NetherlandsRichard W. Costello7Department of Respiratory Medicine, Beaumont Hospital, Dublin, IrelandMarco Gramm21Pulmonary Research Institute at LungClinic Grosshansdorf, Airway Research Center North, Member of the German Centre for Lung Research, Grosshansdorf, GermanyRoger Goldstein26Respiratory Medicine, West Park Healthcare Centre, Toronto, CanadaMiriam Groenen1Department of Research & Education, Center of Expertise for Chronic Organ Failure+ (CIRO+), Horn, NetherlandsHelgo Magnussen21Pulmonary Research Institute at LungClinic Grosshansdorf, Airway Research Center North, Member of the German Centre for Lung Research, Grosshansdorf, GermanyEmiel F.M. Wouters1Department of Research & Education, Center of Expertise for Chronic Organ Failure+ (CIRO+), Horn, Netherlands2Department of Respiratory Medicine, Maastricht University Medical Center+ (MUMC+), Maastricht, NetherlandsRichard L. ZuWallack30Department of Pulmonary and Critical Care, Saint Francis Hospital and Medical Center, Hartford, CT,Oliver Amft3Department of Signal Processing Systems, Technische Universiteit Eindhoven, Eindhoven, Netherlands31ACTLab Group, Chair of Sensor Technology, University Passau, Passau, GermanyHenrik Watz21Pulmonary Research Institute at LungClinic Grosshansdorf, Airway Research Center North, Member of the German Centre for Lung Research, Grosshansdorf, GermanyMartijn A. Spruit1Department of Research & Education, Center of Expertise for Chronic Organ Failure+ (CIRO+), Horn, Netherlands32REVAL - Rehabilitation Research Center, BIOMED - Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium
- Cardiopulmonary exercise test (CPET) may show initial right cardiac dysfunction in patients with moderate-severe chronic obstructive pulmonary disease (COPD)By Laura Malagrinò, Giulia Parri, Frank Dini, Francesco Costa, Sandra Antonelli, Gianna De Cusatis, Claudia De Simone, Sabrina Santerini, Barbara Vagaggini and Pierluigi PaggiaroLaura Malagrinò1Cardiothoracic and Vascular, University of Pisa, Pisa, PI, ItalyGiulia Parri1Cardiothoracic and Vascular, University of Pisa, Pisa, PI, ItalyFrank Dini1Cardiothoracic and Vascular, University of Pisa, Pisa, PI, ItalyFrancesco Costa1Cardiothoracic and Vascular, University of Pisa, Pisa, PI, ItalySandra Antonelli1Cardiothoracic and Vascular, University of Pisa, Pisa, PI, ItalyGianna De Cusatis1Cardiothoracic and Vascular, University of Pisa, Pisa, PI, ItalyClaudia De Simone1Cardiothoracic and Vascular, University of Pisa, Pisa, PI, ItalySabrina Santerini1Cardiothoracic and Vascular, University of Pisa, Pisa, PI, ItalyBarbara Vagaggini1Cardiothoracic and Vascular, University of Pisa, Pisa, PI, ItalyPierluigi Paggiaro1Cardiothoracic and Vascular, University of Pisa, Pisa, PI, Italy
- Once-daily tiotropium respimat add-on to at least ICS maintenance therapy reduces exacerbation risk in patients with uncontrolled symptomatic asthmaBy David Halpin, Eric Bateman, Pierluigi Paggiaro, Eugene Bleecker, Michael Engel, Petra Moroni-Zentgraf, Hendrik Schmidt and Huib KerstjensDavid Halpin1Respiratory Medicine, Royal Devon & Exeter Hospital, Exeter, United KingdomEric Bateman2Department of Medicine, University of Cape Town, Cape Town, South AfricaPierluigi Paggiaro3Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyEugene Bleecker4Center for Genomics and Personalized Medicine, Wake Forest School of Medicine, Winston-Salem, NC,Michael Engel5TA Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, GermanyPetra Moroni-Zentgraf5TA Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, GermanyHendrik Schmidt6Global Biometrics and Clinical Applications, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, GermanyHuib Kerstjens7Department of Pulmonary Medicine, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
- Obesity influences inflammatory phenotype mainly in early onset severe asthmaticsBy Federica Novelli, Letizia Vergura, Manuela Latorre, Elena Bacci, Maria Laura Bartoli, Silvana Cianchetti, Federico Lorenzo Dente, Antonella Di Franco and Pierluigi PaggiaroFederica Novelli1Cardio-Thoracic Department, University of Pisa, Pisa, ItalyLetizia Vergura1Cardio-Thoracic Department, University of Pisa, Pisa, ItalyManuela Latorre1Cardio-Thoracic Department, University of Pisa, Pisa, ItalyElena Bacci1Cardio-Thoracic Department, University of Pisa, Pisa, ItalyMaria Laura Bartoli1Cardio-Thoracic Department, University of Pisa, Pisa, ItalySilvana Cianchetti1Cardio-Thoracic Department, University of Pisa, Pisa, ItalyFederico Lorenzo Dente1Cardio-Thoracic Department, University of Pisa, Pisa, ItalyAntonella Di Franco1Cardio-Thoracic Department, University of Pisa, Pisa, ItalyPierluigi Paggiaro1Cardio-Thoracic Department, University of Pisa, Pisa, Italy
- A summary of the new GINA strategy: a roadmap to asthma controlBy Helen K. Reddel, Eric D. Bateman, Allan Becker, Louis-Philippe Boulet, Alvaro A. Cruz, Jeffrey M. Drazen, Tari Haahtela, Suzanne S. Hurd, Hiromasa Inoue, Johan C. de Jongste, Robert F. Lemanske, Mark L. Levy, Paul M. O'Byrne, Pierluigi Paggiaro, Soren E. Pedersen, Emilio Pizzichini, Manuel Soto-Quiroz, Stanley J. Szefler, Gary W.K. Wong and J. Mark FitzGeraldArticle | Published in 2015 in European Respiratory JournalHelen K. Reddel1Woolcock Institute of Medical Research, University of Sydney, Sydney, AustraliaEric D. Bateman2University of Cape Town Lung Institute, Cape Town, South AfricaAllan Becker3University of Manitoba, Winnipeg, MB, CanadaLouis-Philippe Boulet4Quebec Heart and Lung Institute, Laval University, Québec City, QC, CanadaAlvaro A. Cruz5Federal University of Bahia, Salvador, BrazilJeffrey M. Drazen6Harvard Medical School, Boston, MA, USATari Haahtela7Helsinki University Central Hospital, Helsinki, FinlandSuzanne S. Hurd8Global Initiative for Asthma, Vancouver, WA, USAHiromasa Inoue9Kagoshima University, Kagoshima, JapanJohan C. de Jongste10Dept of Pediatrics, Erasmus University Medical Centre, Rotterdam, The NetherlandsRobert F. Lemanske Jr11University of Wisconsin, Madison, WI, USAMark L. Levy12General Practitioner, London, UKPaul M. O'Byrne13Firestone Institute of Respiratory Health, St. Joseph's Healthcare and McMaster University, Hamilton, ON, CanadaPierluigi Paggiaro14University of Pisa, Pisa, ItalySoren E. Pedersen15Pediatric Research Unit, University of Southern Denmark, Kolding Hospital, Kolding, DenmarkEmilio Pizzichini16Universidade Federal de Santa Catarina, NUPAIVA Asthma Research Centre, Florianópolis, BrazilManuel Soto-Quiroz17National Childreńs Hospital, University of Costa Rica San Jose, San Jose, Costa RicaStanley J. Szefler18Children's Hospital Colorado, Aurora, CO, USAGary W.K. Wong19Dept of Paediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong KongJ. Mark FitzGerald20Institute for Heart and Lung Health, University of British Columbia, Vancouver, BC, Canada
- A summary of the new GINA strategy: a roadmap to asthma controlBy Helen K. Reddel, Eric D. Bateman, Allan Becker, Louis-Philippe Boulet, Alvaro A. Cruz, Jeffrey M. Drazen, Tari Haahtela, Suzanne S. Hurd, Hiromasa Inoue, Johan C. de Jongste, Robert F. Lemanske, Mark L. Levy, Paul M. O'Byrne, Pierluigi Paggiaro, Soren E. Pedersen, Emilio Pizzichini, Manuel Soto-Quiroz, Stanley J. Szefler, Gary W.K. Wong and J. Mark FitzGeraldHelen K. Reddel1Woolcock Institute of Medical Research, University of Sydney, Sydney, AustraliaEric D. Bateman2University of Cape Town Lung Institute, Cape Town, South AfricaAllan Becker3University of Manitoba, Winnipeg, MB, CanadaLouis-Philippe Boulet4Quebec Heart and Lung Institute, Laval University, Québec City, QC, CanadaAlvaro A. Cruz5Federal University of Bahia, Salvador, BrazilJeffrey M. Drazen6Harvard Medical School, Boston, MA, USATari Haahtela7Helsinki University Central Hospital, Helsinki, FinlandSuzanne S. Hurd8Global Initiative for Asthma, Vancouver, WA, USAHiromasa Inoue9Kagoshima University, Kagoshima, JapanJohan C. de Jongste10Dept of Pediatrics, Erasmus University Medical Centre, Rotterdam, The NetherlandsRobert F. Lemanske Jr11University of Wisconsin, Madison, WI, USAMark L. Levy12General Practitioner, London, UKPaul M. O'Byrne13Firestone Institute of Respiratory Health, St. Joseph's Healthcare and McMaster University, Hamilton, ON, CanadaPierluigi Paggiaro14University of Pisa, Pisa, ItalySoren E. Pedersen15Pediatric Research Unit, University of Southern Denmark, Kolding Hospital, Kolding, DenmarkEmilio Pizzichini16Universidade Federal de Santa Catarina, NUPAIVA Asthma Research Centre, Florianópolis, BrazilManuel Soto-Quiroz17National Childreńs Hospital, University of Costa Rica San Jose, San Jose, Costa RicaStanley J. Szefler18Children's Hospital Colorado, Aurora, CO, USAGary W.K. Wong19Dept of Paediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong KongJ. Mark FitzGerald20Institute for Heart and Lung Health, University of British Columbia, Vancouver, BC, Canada
- Particulate matter-induced microparticle generation by human endothelial cells: A novel link between cardiopulmonary diseases and airborne pollutantsBy Tommaso Neri, Laura Pergoli, Silvia Petrini, Francesca Faita, Cristina Balia, Valentina Scalise, Mirjam Hoxha, Federica Rota, Roberto Pedrinelli, Pierluigi Paggiaro, Valentina Bollati and Alessandro CeliTommaso Neri1Dipartimento di Patologia Chirurgica, Medica, Molecolare e di Area Critica, University of Pisa, Pisa, ItalyLaura Pergoli2Dipartimento di Scienze Cliniche e di Comunità "Clinica del Lavoro Luigi Devoto", University of Milan, Milan, ItalySilvia Petrini1Dipartimento di Patologia Chirurgica, Medica, Molecolare e di Area Critica, University of Pisa, Pisa, ItalyFrancesca Faita1Dipartimento di Patologia Chirurgica, Medica, Molecolare e di Area Critica, University of Pisa, Pisa, ItalyCristina Balia1Dipartimento di Patologia Chirurgica, Medica, Molecolare e di Area Critica, University of Pisa, Pisa, ItalyValentina Scalise1Dipartimento di Patologia Chirurgica, Medica, Molecolare e di Area Critica, University of Pisa, Pisa, ItalyMirjam Hoxha2Dipartimento di Scienze Cliniche e di Comunità "Clinica del Lavoro Luigi Devoto", University of Milan, Milan, ItalyFederica Rota2Dipartimento di Scienze Cliniche e di Comunità "Clinica del Lavoro Luigi Devoto", University of Milan, Milan, ItalyRoberto Pedrinelli1Dipartimento di Patologia Chirurgica, Medica, Molecolare e di Area Critica, University of Pisa, Pisa, ItalyPierluigi Paggiaro1Dipartimento di Patologia Chirurgica, Medica, Molecolare e di Area Critica, University of Pisa, Pisa, ItalyValentina Bollati2Dipartimento di Scienze Cliniche e di Comunità "Clinica del Lavoro Luigi Devoto", University of Milan, Milan, ItalyAlessandro Celi1Dipartimento di Patologia Chirurgica, Medica, Molecolare e di Area Critica, University of Pisa, Pisa, Italy
- Determinants of cardio-pulmonary exercise test (CPET) and shuttle walking test (SWT) in COPD patients are differentBy Francesco Costa, Dario Nieri, Maria Laura Bartoli, Sandra Antonelli, Gianna Decusatis, Claudia De Simone, Laura Malagrinò, Sabrina Santerini, Barbara Vagaggini and Pierluigi PaggiaroFrancesco CostaCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyDario NieriCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyMaria Laura BartoliCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalySandra AntonelliCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyGianna DecusatisCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyClaudia De SimoneCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyLaura MalagrinòCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalySabrina SanteriniCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyBarbara VagagginiCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyPierluigi PaggiaroCardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy
- Which are the main determinants of quality-of-life in severe asthma?By Federica Novelli, Letizia Vergura, Manuela Latorre, Elena Bacci, Silvana Cianchetti, Federico Dente, Antonelli Di Franco and Pierluigi PaggiaroFederica NovelliCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyLetizia VerguraCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyManuela LatorreCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyElena BacciCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalySilvana CianchettiCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyFederico DenteCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyAntonelli Di FrancoCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyPierluigi PaggiaroCardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy
- Nasal disease in chronic severe asthma (CSA) and eosinophilic granulomatosis with poliangiitis (EGPA)By Manuela Latorre, Veronica Seccia, Chiara Baldini, Letizia Vergura, Federica Novelli, Marias Laura Bartoli, Silvana Cianchetti, Elena Bacci, Federico Dente, Antonella Di Franco and Pierluigi PaggiaroManuela Latorre1Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyVeronica Seccia2ENT Unit, University of Pisa, Pisa, ItalyChiara Baldini3Rheumatology Unit, University of Pisa, Pisa, ItalyLetizia Vergura1Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyFederica Novelli1Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyMarias Laura Bartoli1Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalySilvana Cianchetti1Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyElena Bacci1Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyFederico Dente1Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyAntonella Di Franco1Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyPierluigi Paggiaro1Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy
- Sputum neutrophils and functional status in non-cystic fibrosis bronchiectasis (NCFB) is related to microbial colonizationBy Federico Lorenzo Dente, Marta Bilotta, Manuela Latorre, Letizia Vergura, Silvana Cianchetti, Barbara Vagaggini and Pierluigi PaggiaroFederico Lorenzo DenteCardio-Tharacic and Vascular Department - Respiratory Pathophysiology Section, University Hospital of Pisa, PISA, ItalyMarta BilottaCardio-Tharacic and Vascular Department - Respiratory Pathophysiology Section, University Hospital of Pisa, PISA, ItalyManuela LatorreCardio-Tharacic and Vascular Department - Respiratory Pathophysiology Section, University Hospital of Pisa, PISA, ItalyLetizia VerguraCardio-Tharacic and Vascular Department - Respiratory Pathophysiology Section, University Hospital of Pisa, PISA, ItalySilvana CianchettiCardio-Tharacic and Vascular Department - Respiratory Pathophysiology Section, University Hospital of Pisa, PISA, ItalyBarbara VagagginiCardio-Tharacic and Vascular Department - Respiratory Pathophysiology Section, University Hospital of Pisa, PISA, ItalyPierluigi PaggiaroCardio-Tharacic and Vascular Department - Respiratory Pathophysiology Section, University Hospital of Pisa, PISA, Italy
- 2011 GOLD categories may identify different copd phenotypesBy Maria Laura Bartoli, Dario Nieri, Sandra Antonelli, Francesco Costa, Gianna Decusatis, Claudia De Simone, Laura Malagrinò, Sabrina Santerini, Barbara Vagaggini and Pierluigi PaggiaroMaria Laura BartoliCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyDario NieriCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalySandra AntonelliCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyFrancesco CostaCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyGianna DecusatisCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyClaudia De SimoneCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyLaura MalagrinòCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalySabrina SanteriniCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyBarbara VagagginiCardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyPierluigi PaggiaroCardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy
- Sputum inflammatory cells in COPD patients classified according to GOLD 2011 guidelinesBy Maria Laura Bartoli, Francesco Costa, Laura Malagrinò, Dario Nieri, Sandra Antonelli, Giovanna Decusatis, Claudia De Simone, Sabrina Santerini, Silvana Cianchetti, Manuela La Torre, Barbara Vagaggini and Pierluigi PaggiaroArticle | Published in 2016 in European Respiratory JournalMaria Laura BartoliCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalyFrancesco CostaCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalyLaura MalagrinòCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalyDario NieriCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalySandra AntonelliCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalyGiovanna DecusatisCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalyClaudia De SimoneCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalySabrina SanteriniCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalySilvana CianchettiCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalyManuela La TorreCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalyBarbara VagagginiCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalyPierluigi PaggiaroCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, Italy
- Sputum inflammatory cells in COPD patients classified according to GOLD 2011 guidelinesBy Maria Laura Bartoli, Francesco Costa, Laura Malagrinò, Dario Nieri, Sandra Antonelli, Giovanna Decusatis, Claudia De Simone, Sabrina Santerini, Silvana Cianchetti, Manuela Latorre, Barbara Vagaggini and Pierluigi PaggiaroMaria Laura BartoliCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalyFrancesco CostaCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalyLaura MalagrinòCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalyDario NieriCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalySandra AntonelliCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalyGiovanna DecusatisCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalyClaudia De SimoneCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalySabrina SanteriniCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalySilvana CianchettiCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalyManuela LatorreCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalyBarbara VagagginiCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, ItalyPierluigi PaggiaroCardio-Thoracic and Vascular Department, Respiratory Pathophysiology and Rehabilitation Unit, University Hospital of Pisa, Italy
- BronchiectasisEdited by James D. Chalmers, Eva Polverino and Stefano AlibertiBook | Published in 2018DOI: 10.1183/2312508X.erm8118ISBN (electronic): 978-1-84984-098-9James D. ChalmersEva Polverino
- Table 4.By Federico L. Dente, Maria Adelaide Roggi, Roberta Del Cesta, Eva Polverino and Pierluigi PaggiaroBook | Published in 1970
This is a PDF-only article. The first page of the PDF of this article appears above.
Federico L. DenteMaria Adelaide RoggiRoberta Del CestaEva PolverinoPierluigi Paggiaro - Table 3By Federico L. Dente, Maria Adelaide Roggi, Roberta Del Cesta, Eva Polverino and Pierluigi PaggiaroBook | Published in 1970
This is a PDF-only article. The first page of the PDF of this article appears above.
Federico L. DenteMaria Adelaide RoggiRoberta Del CestaEva PolverinoPierluigi Paggiaro - Table 2.By Federico L. Dente, Maria Adelaide Roggi, Roberta Del Cesta, Eva Polverino and Pierluigi PaggiaroBook | Published in 1970
This is a PDF-only article. The first page of the PDF of this article appears above.
Federico L. DenteMaria Adelaide RoggiRoberta Del CestaEva PolverinoPierluigi Paggiaro - Table 1By Federico L. Dente, Maria Adelaide Roggi, Roberta Del Cesta, Eva Polverino and Pierluigi PaggiaroBook | Published in 1970
This is a PDF-only article. The first page of the PDF of this article appears above.
Federico L. DenteMaria Adelaide RoggiRoberta Del CestaEva PolverinoPierluigi Paggiaro
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.